Archives: Speakers

Juliette is a real estate industry leader with 20 years’ experience working internationally. She has managed portfolios of millions of sq ft in development and asset management and latterly focussed her career on ESG strategies in the built environment. She led pathways to net zero and offset for a UK based REIT, British Land and is now a leader in Gensler’s Global Climate action and Sustainability Practice Area working with clients all over the globe to reduce their carbon impact, and increase their human and biodiversity outcomes.

Nicolas Rivollet has 20 years of international experience with PET packaging for consumer goods. With Penn Color, he combines creativity and a rigorous analytical approach to shape strategies to expand product vitality and develop new business in the US, Europe, and Asia. Before joining Penn Color, he had roles with Sidel as Marketing VP Blowing & Coating, Sales Support & Technical Communication in Octeville Sur Mer, France, Project Director, Supply Chain Director in Kuala Lumpur, Malaysia, and Product Innovation Director, Blowing & Coating in France. He also was Director of Corporate Business Development for Husky in Toronto. Nicolas has a degree from INSA Lyon – Institut National des Sciences Appliquées de Lyon, attended IAE FRANCE – Écoles Universitaires de Management, and has an MBA from the University of Pennsylvania Wharton School.

Christine McSherry founded Jett Foundation in 2001, when her son now 24-year-old Jett was diagnosed with Duchenne Muscular Dystrophy. As head of the Jett Foundation, Christine co-founded the International Duchenne Alliance, a partnership of over 40 independent organizations that has funded nearly $15 million dollars in research to date.

Christine has advocated for the patient perspective to be considered by the FDA when reviewing safe and potentially effective treatments for Duchenne. In April of 2016, Christine presented the Jett Foundation’s Patient Centered Outcomes report at the FDA’s meeting of the Peripheral and Central Nervous System Drugs Advisory Committee.

A product evangelist with 15 years of experience in the financial services industry. He has previously worked with companies like Visa, 10x Banking and Metro Bank. Currently, the Product Director at Monese, leading product propositions across Credit, Savings and Investments.

Kris O’Brien is an Executive Director in Program Strategy, specializing in Rare Disease and Pediatrics, at Premier Research. Ms. O’Brien has been conducting clinical research for more than 35 years and has covered multiple functions during that time. Her experience in a multitude of therapeutic indications has led to an acute knowledge of study conduct and execution with a keen focus on protocol dynamics. This experience has allowed her to understand the nuances that set rare and pediatric studies apart from routine clinical studies and develop proper strategies for clients to execute their studies in real world settings.

Experienced quality professional with strong leadership and exceptional background in packaging operations, technology, clinical supplies, commercial products, laboratory, and FDA & EU regulatory agency compliance and inspections. Cross functional roles include 2 interim clinical supply assignments, direct line supervision of Global Quality, Sterile & Biological Operations/Technology and Pharm Laboratory personnel.  Key in the development of Expanded Access Program at her company.